BACE1 and Cognitive impairment: While recent studies indicate that complete blockage of BACE1 activity may be associated with certain undesirable side-effects, important data demonstrates that partial reduction of BACE1 levels may improve cognitive deficits and amyloid neuropathology including Aβ deposition, at least in specific AD Tg models.